Last updated on 12 Feb 2025
Owner Info
Iovance Biotherapeutics, Inc.
825 Industrial Road, Suite 400
San Carlos CA 94070, UNITED STATES OF AMERICA
Serial Number
2333140 filed on 16 Sept 2022
Correspondent
Carla B. Oakley Morgan, Lewis & Bockius LLP
One Market, Spear Street Tower,
San Francisco CA 94105,
UNITED STATES OF AMERICA
2333140
16 Sept 2022
NA
WORD
18 Mar 2022
US
Status Date | Action Taken |
---|---|
12th Feb 2025 | Status change to Voided |
9th May 2023 | International Registration in Australia Protected correspondence sent |
8th May 2023 | IP Right Registration Published |
8th May 2023 | Status change to Registered/Protected |
2th Mar 2023 | Application Accepted correspondence sent |
1st Mar 2023 | IP Right has been Examined |
1st Mar 2023 | IP Right Acceptance Published |
1st Mar 2023 | Status change to Accepted |
15th Feb 2023 | Examination expedited |
15th Feb 2023 | Awaiting examination |